| Dr Eva Marie Martin, MD | |
|
1991 Sproul Rd Ste 200, Broomall, PA 19008-3518 | |
| (610) 325-1350 | |
| (610) 325-3518 |
| Full Name | Dr Eva Marie Martin |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 11 Years |
| Location | 1991 Sproul Rd Ste 200, Broomall, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659710283 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | MD461512 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Main Line Hospital Lankenau | Wynnewood, PA | Hospital |
| Bryn Mawr Hospital | Bryn mawr, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Main Line Healthcare | 1951215201 | 894 |
News Archive
BioCryst Pharmaceuticals, Inc. today announced that the Company had been awarded $1.1 million in grants under the U.S. Government's Qualifying Therapeutic Discovery Project (QTDP) program to advance the development of the Company's clinical programs for peramivir, BCX4208 and forodesine, as well as the pre-clinical BCX4161 kallikrein inhibitor and JAK inhibitor programs.
A urine test that can detect early stage pancreatic cancer has reached the final stage of validation before being developed for use with patients.
Pyrexar Medical begins operations today after completing the acquisition of hyperthermia assets held by Perseon, formerly BSD Medical. This acquisition includes substantially all hyperthermia assets, products, services and related intellectual property.
The products of Titertek-Berthold / Berthold Detection Systems GmbH and the life science business of Berthold Technologies GmbH & Co. KG ("Bioanalytic") have been trusted by scientists in basic research, pharmaceutical, biomedical and applied markets laboratories across the globe for more than half a century.
› Verified 7 days ago
| Entity Name | Main Line Healthcare |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922077643 PECOS PAC ID: 1951215201 Enrollment ID: O20040308000373 |
News Archive
BioCryst Pharmaceuticals, Inc. today announced that the Company had been awarded $1.1 million in grants under the U.S. Government's Qualifying Therapeutic Discovery Project (QTDP) program to advance the development of the Company's clinical programs for peramivir, BCX4208 and forodesine, as well as the pre-clinical BCX4161 kallikrein inhibitor and JAK inhibitor programs.
A urine test that can detect early stage pancreatic cancer has reached the final stage of validation before being developed for use with patients.
Pyrexar Medical begins operations today after completing the acquisition of hyperthermia assets held by Perseon, formerly BSD Medical. This acquisition includes substantially all hyperthermia assets, products, services and related intellectual property.
The products of Titertek-Berthold / Berthold Detection Systems GmbH and the life science business of Berthold Technologies GmbH & Co. KG ("Bioanalytic") have been trusted by scientists in basic research, pharmaceutical, biomedical and applied markets laboratories across the globe for more than half a century.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Eva Marie Martin, MD 1991 Sproul Rd Ste 200, Broomall, PA 19008-3518 Ph: (610) 325-1350 | Dr Eva Marie Martin, MD 1991 Sproul Rd Ste 200, Broomall, PA 19008-3518 Ph: (610) 325-1350 |
News Archive
BioCryst Pharmaceuticals, Inc. today announced that the Company had been awarded $1.1 million in grants under the U.S. Government's Qualifying Therapeutic Discovery Project (QTDP) program to advance the development of the Company's clinical programs for peramivir, BCX4208 and forodesine, as well as the pre-clinical BCX4161 kallikrein inhibitor and JAK inhibitor programs.
A urine test that can detect early stage pancreatic cancer has reached the final stage of validation before being developed for use with patients.
Pyrexar Medical begins operations today after completing the acquisition of hyperthermia assets held by Perseon, formerly BSD Medical. This acquisition includes substantially all hyperthermia assets, products, services and related intellectual property.
The products of Titertek-Berthold / Berthold Detection Systems GmbH and the life science business of Berthold Technologies GmbH & Co. KG ("Bioanalytic") have been trusted by scientists in basic research, pharmaceutical, biomedical and applied markets laboratories across the globe for more than half a century.
› Verified 7 days ago
Dr. Randolph P. Heinzel, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1991 Sproul Rd, Suite 200, Broomall, PA 19008 Phone: 610-325-1350 Fax: 610-325-1357 | |
Beverly Ann Eisenhuth, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1991 Sproul Rd, Suite 200, Broomall, PA 19008 Phone: 610-325-1350 Fax: 610-325-1357 | |
Dr. Rudolf L Laveran-stiebar, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1991 Sproul Rd, Suite 200 Main Line Health Center, Broomall, PA 19008 Phone: 610-325-1350 Fax: 610-325-1357 | |
Dr. Edwina Navasha Coleman, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1991 Sproul Rd Ste 300, Broomall, PA 19008 Phone: 610-325-1390 Fax: 610-325-1373 | |
Courtney B Hammerel, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1991 Sproul Rd, Suite 200, Broomall, PA 19008 Phone: 610-325-1350 Fax: 610-325-1357 | |
Dr. Sharon F Rudo, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1991 Sproul Rd, Suite 200, Broomall, PA 19008 Phone: 610-325-1350 Fax: 610-325-1357 |